Cargando…

Targeting SARS‐CoV‐2 infection through CAR‐T‐like bispecific T cell engagers incorporating ACE2

OBJECTIVES: Despite advances in antibody treatments and vaccines, COVID‐19 caused by SARS‐CoV‐2 infection remains a major health problem resulting in excessive morbidity and mortality and the emergence of new variants has reduced the effectiveness of current vaccines. METHODS: Here, as a proof‐of‐co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dogan, Mikail, Kozhaya, Lina, Placek, Lindsey, Karabacak, Fatih, Yigit, Mesut, Unutmaz, Derya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586837/ https://www.ncbi.nlm.nih.gov/pubmed/36285327 http://dx.doi.org/10.1002/cti2.1421

Ejemplares similares

SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus
por: Dogan, Mikail, et al.
Publicado: (2021)

Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease
por: Dailey, Joelynn, et al.
Publicado: (2021)

731 FAILURE TO DEVELOP NEUTRALIZING ANTIBODIES FOLLOWING SARS-COV-2 INFECTION IN YOUNG PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECEIVING BIOLOGICS
por: Dailey, Joelynn, et al.
Publicado: (2021)

Expression and Function of TNF and IL-1 Receptors on Human Regulatory T Cells
por: Mercer, Frances, et al.
Publicado: (2010)

Identification of a Regulatory T Cell Specific Cell Surface Molecule that Mediates Suppressive Signals and Induces Foxp3 Expression
por: Wang, Rui, et al.
Publicado: (2008)

Tuning of human MAIT cell activation by commensal bacteria species and MR1 dependent T cell presentation
por: Tastan, Cihan, et al.
Publicado: (2018)

The Metalloprotease ADAM12 Regulates the Effector Function of Human Th17 Cells
por: Zhou, Angela X., et al.
Publicado: (2013)

Elimination of HIV-1-Infected Primary T Cell Reservoirs in an In Vitro Model of Latency
por: Rawlings, Stephen A., et al.
Publicado: (2015)

Probing the Effector and Suppressive Functions of Human T Cell Subsets Using Antigen-Specific Engineered T Cell Receptors
por: Wan, Qi, et al.
Publicado: (2013)

Correction: Probing the Effector and Suppressive Functions of Human T Cell Subsets Using Antigen-Specific Engineered T Cell Receptors
por: Wan, Qi, et al.
Publicado: (2013)

Perturbation of the P-Body Component Mov10 Inhibits HIV-1 Infectivity
por: Furtak, Vyacheslav, et al.
Publicado: (2010)

A genome–wide CRISPR activation screen identifies SCREEM a novel SNAI1 super-enhancer demarcated by eRNAs
por: Uthaya Kumar, Dinesh Babu, et al.
Publicado: (2023)

Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6(+) human memory T cells
por: Wan, Qi, et al.
Publicado: (2011)

A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)
por: Stone, Jennifer D., et al.
Publicado: (2012)

Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease
por: Limgala, Renuka Pudi, et al.
Publicado: (2016)

Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells
por: Thakur, Archana, et al.
Publicado: (2021)

The race is on: bispecifics vs CAR T cells in B-cell lymphoma
por: Gurumurthi, Ashwath, et al.
Publicado: (2023)

Conduit CAR: Redirecting CAR T-Cell Specificity with A Universal and Adaptable Bispecific Antibody Platform
por: Borrok, M. Jack, et al.
Publicado: (2022)

GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma
por: Park, Jeong A., et al.
Publicado: (2020)

The landscape of bispecific T cell engager in cancer treatment
por: Zhou, Shujie, et al.
Publicado: (2021)

CCR5 is a receptor for Staphylococcus aureus leukotoxin ED
por: III, Francis Alonzo, et al.
Publicado: (2012)

A Focus on CAR T-Cell Therapy and Bispecific Antibodies in Multiple Myeloma
por: Catamero, Donna, et al.
Publicado: (2022)

Bispecific GPC3/PD-1 CAR-T cells for the treatment of HCC
por: Li, Dezhi, et al.
Publicado: (2023)

Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer
por: Zarrabi, Kevin K., et al.
Publicado: (2023)

Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids
por: Ramesh, Radha, et al.
Publicado: (2014)

For whom the T cells troll? Bispecific T-cell engagers in glioblastoma
por: Singh, Kirit, et al.
Publicado: (2021)

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
por: Grada, Zakaria, et al.
Publicado: (2013)

Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
por: Huckaby, Justin T, et al.
Publicado: (2021)

Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation
por: Arenas, Enrique J., et al.
Publicado: (2021)

Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple Myeloma
por: Golubovskaya, Vita, et al.
Publicado: (2021)

Dual targeting ovarian cancer by Muc16 CAR-T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1
por: Mun, Sung Soo, et al.
Publicado: (2023)

Therapeutic Bispecific T-Cell Engager Antibody Targeting the Transferrin Receptor
por: Fu, Mingpeng, et al.
Publicado: (2019)

Overcoming leukemia heterogeneity by combining T cell engaging bispecific antibodies
por: Hoseini, Sayed Shahabuddin, et al.
Publicado: (2020)

Bispecific T-Cell Engagers Targeting Membrane-Bound IgE
por: Rodak, Aleksandra, et al.
Publicado: (2021)

Bispecific T cell engagers: an emerging therapy for management of hematologic malignancies
por: Tian, Zheng, et al.
Publicado: (2021)

Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies
por: Poussin, Mathilde, et al.
Publicado: (2021)

Bispecific T Cell Engagers for the Treatment of Multiple Myeloma: Achievements and Challenges
por: Alhallak, Kinan, et al.
Publicado: (2021)

Combination therapies for the optimisation of Bispecific T-cell Engagers in cancer treatment
por: Zhu, Winston M, et al.
Publicado: (2023)

Simultaneous Multiple Interaction T-cell Engaging (SMITE) Bispecific Antibodies Overcome Bispecific T-cell Engager (BiTE) Resistance Via CD28 Co-Stimulation
por: Correnti, Colin E., et al.
Publicado: (2018)

Role of Vitamin D, ACE2 and the Proteases as TMPRSS2 and Furin on SARS-CoV-2 Pathogenesis and COVID-19 Severity
por: Ortatatli, Mesut, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5vlh3l220jiur1c21vtl5855hh